Correlation Between Editas Medicine and Novartis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Editas Medicine and Novartis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Editas Medicine and Novartis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Editas Medicine and Novartis AG ADR, you can compare the effects of market volatilities on Editas Medicine and Novartis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Editas Medicine with a short position of Novartis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Editas Medicine and Novartis.

Diversification Opportunities for Editas Medicine and Novartis

0.35
  Correlation Coefficient

Weak diversification

The 3 months correlation between Editas and Novartis is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Editas Medicine and Novartis AG ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novartis AG ADR and Editas Medicine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Editas Medicine are associated (or correlated) with Novartis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novartis AG ADR has no effect on the direction of Editas Medicine i.e., Editas Medicine and Novartis go up and down completely randomly.

Pair Corralation between Editas Medicine and Novartis

Given the investment horizon of 90 days Editas Medicine is expected to under-perform the Novartis. In addition to that, Editas Medicine is 4.57 times more volatile than Novartis AG ADR. It trades about -0.14 of its total potential returns per unit of risk. Novartis AG ADR is currently generating about 0.04 per unit of volatility. If you would invest  10,304  in Novartis AG ADR on November 18, 2024 and sell it today you would earn a total of  239.00  from holding Novartis AG ADR or generate 2.32% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Editas Medicine  vs.  Novartis AG ADR

 Performance 
       Timeline  
Editas Medicine 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Editas Medicine has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's forward indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Novartis AG ADR 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Novartis AG ADR are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Novartis is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Editas Medicine and Novartis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Editas Medicine and Novartis

The main advantage of trading using opposite Editas Medicine and Novartis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Editas Medicine position performs unexpectedly, Novartis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novartis will offset losses from the drop in Novartis' long position.
The idea behind Editas Medicine and Novartis AG ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets